Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.355 +0.165 (+2.01%)
Streaming Delayed Price Updated: 1:02 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
61 62 Next >
Why Novavax Stock Is Rising Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Wednesday after the U.S. 
Via Benzinga
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
CDC Advisory Committee Recommends Novavax's COVID-19 Vaccine For Adults
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... 
Via Benzinga
2 Big Reasons Novavax (NVAX) Stock Is Shooting Higher Today
Novavax has several catalysts igniting NVAX stock higher today. The bulls hope this is just the beginning for NVAX shares. 
Via InvestorPlace
Why Novavax Stock Is Surging Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday as CDC advisers meet to discuss the company's COVID-19 vaccine. 
Via Benzinga
Why Novavax Shares Are Plunging Today Despite Much Awaited FDA Emergency Nod?
Via Benzinga
Novavax Sinks Despite Winning FDA Authorization For Its Covid Vaccine
The authorization comes a month after the key advisory committee meeting. 
Via Investor's Business Daily
Is it Time to Cash Out Novavax Stock?
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S. 
Via MarketBeat
Exposures COVID-19 Product Safety
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
Via Benzinga
Is Novavax (NVAX) Stock a Buy After FDA Decision?
Novavax (NVAX) stock is in the spotlight on Friday as investors react to recent FDA news concerning its Covid-19 vaccine. 
Via InvestorPlace
Nasdaq Turns Positive; Morgan Stanley Posts Weak Q2 Earnings
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite turning higher on Thursday. 
Via Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Dow Sinks Amid Disappointing Data, Bank Earnings
Wall Street worries over potential rate hikes from the Fed following yesterday's inflation reading. 
Via Talk Markets
Dow Tumbles 450 Points; JPMorgan Shares Drop Following Earnings Miss
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday. 
Via Benzinga
Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session
Gainers Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume. 
Via Benzinga
Why Is TransGlobe Energy (TGA) Stock Up 2% Today?
TransGlobe Energy (TGA) stock is gaining on Thursday as investors react to news of a merger agreement with Vaalco Energy (EGY). 
Via InvestorPlace
What Is Going on With Novavax (NVAX) Stock Today?
NVAX stock is falling on news that European regulators have placed a new warning on the company's Covid-19 vaccine. 
Via InvestorPlace
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga Before The Bell: Tesla's AI Exec Quits, Hyundai Unveils Ioniq 6 EV, Taiwan Semiconductor's Massive Q2 Profit Surge And Other Top Financial Stories Thursday, July 14
CNBC United Airlines, Pilots’ Union To Improve Agreement By Renegotiating 
Via Benzinga
U.S. Stock Futures Down Ahead Of Bank Earnings, Producer Price Index
Pre-open movers 
Via Benzinga
JPMorgan, Morgan Stanley And 3 Stocks To Watch Heading Into Thursday
With the US stock futures trading lower this morning on Tuesday ahead of earnings from big banks, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Novavax Secures FDA Emergency Authorization For Adjuvanted Covid-19 Vaccine
The U.S. Food and Drug Administration (FDA) grants emergency use authorization (EUA) to Novavax’s (NASDAQ: NVAX) lead candidate Adjuvanted (NVX-CoV2373) COVID-19 Vaccine for individuals 18 years of age... 
Via Benzinga
PSNY Stock Alert: Polestar Announces 125% Sales Increase So Far in 2022
Polestar Automotive (PSNY) stock is rising higher on Wednesday following an update on the company's performance in 2022. 
Via InvestorPlace
Why Is Humanigen (HGEN) Stock Plunging 79% Today?
Humanigen (HGEN) stock is falling hard on Wednesday following the release of preliminary results from a Covid-19 clinical trial. 
Via InvestorPlace
Novavax (NVAX) Stock Pops Ahead of FDA Approval
NVAX stock has risen nearly 10% in the past five trading sessions on expectations that the FDA is going to approve its Covid-19 vaccine. 
Via InvestorPlace
More Vaccine Jabs Means Novavax Stock Is Up for Grabs
NVAX stock looks due for a bounce-back as Novavax makes strides in providing Covid-19 vaccines in the U.S. and internationally. 
Via InvestorPlace
The Good News For Moderna's Covid Shot Barely Moved Its Stock
Moderna stock reacted minimally to positive results for its updated Covid booster. 
Via Investor's Business Daily
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.